×

img Acces sibility Controls

Research Projects Banner

Research Projects

Therapeutic Significance of MARCKS Signaling Axis in Ovarian Cancer Metastasis: A Precision Anti-Metastatic Therapy Approach

Implementing Organization

Principal Investigator
Dr. Purusottam Mohapatra
DBT Ramalingaswami Fellow
|
National Institute Of Pharmaceutical Education And Research (Niper-G)
CO-Principal Investigator
Dr. Sudhagar S
National Institute Of Pharmaceutical Education And Research (Niper-G)

Project Overview

Metastasis is a complex process that often leads to poor prognosis in patients with metastatic cancers. The cellular signaling associated with metastatic events is not fully understood, particularly in ovarian cancer. The Myristoylated Alanine Rich C Kinase (MARCKS) signaling is known to play a role in cancer cell migration and invasion, but its significance in ovarian cancer metastasis is still unknown. This project proposes to demonstrate the expression and phosphorylation patterns of MARCKS in different grades of ovarian carcinoma patient-derived tumor samples, investigate the detailed MARCKS signaling cascade in ovarian cancer models, and develop a therapeutic strategy against metastatic ovarian cancer using modified MARCKS phosphorylation-specific peptide candidates in in vivo preclinical mouse models.
Funding Organization
Funding Organization

Quick Information
Area of Research
Pharmaceutical Sciences
Focus Area
Biotechnology, Ovarian Cancer Metastasis
Start Year
2022
Sanction Amount
₹ 59.42 L
Status
Ongoing
Output
No. of Research Paper
00
Technologies (If Any)
00
No. of PhD Produced
N/A
Startup (If Any)
00
No. of Patents
Filed :00
Grant :00
arrowtop